01 42CATALYST PHARMS
01 356949571
02 78772497
01 42Y
01 35Y
02 7Blank
01 352025-05-23
02 72026-07-01
Patent Expiration Date : 2025-05-23
US Patent Number : 6949571
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 202834
Patent Use Code : U-2429
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-05-23
Patent Expiration Date : 2025-05-23
US Patent Number : 6949571
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 202834
Patent Use Code : U-2428
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-05-23
Patent Expiration Date : 2025-05-23
US Patent Number : 6949571
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 202834
Patent Use Code : U-2088
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-05-23
Patent Expiration Date : 2025-05-23
US Patent Number : 6949571
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 202834
Patent Use Code : U-2089
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-05-23
Patent Expiration Date : 2025-05-23
US Patent Number : 6949571
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 202834
Patent Use Code : U-2088
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-05-23
Patent Expiration Date : 2025-05-23
US Patent Number : 6949571
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 202834
Patent Use Code : U-106
Delist Requested :
Patent Use Description : TREATMENT OF EPILEPSY
Patent Expiration Date : 2025-05-23
Patent Expiration Date : 2025-05-23
US Patent Number : 6949571
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 202834
Patent Use Code : U-2429
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-05-23
Patent Expiration Date : 2025-05-23
US Patent Number : 6949571
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 202834
Patent Use Code : U-2428
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-05-23
Patent Expiration Date : 2025-05-23
US Patent Number : 6949571
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 202834
Patent Use Code : U-2428
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-05-23
Patent Expiration Date : 2025-05-23
US Patent Number : 6949571
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 202834
Patent Use Code : U-2089
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-05-23
